.png){kind=icon}
-
Commercialization
市场访问和第IV阶段解决方案
-
Data & Technology Solutions
Data Capabilities Design Better Studies Improve Study Recruitment 减少研究风险 Gain Operational Insights Ensure Data Quality Access Central Laboratory Information Empower Your Data Maximize Product Access Transform Patient SafetyClinical Trials
Clinical Pharmacology Early Clinical 晚期临床 第四阶段& RWE 数据分析与报告 Global Compliance CRU Virtual Tours 分散和虚拟化 PoC Studies
-
Call Us
The Americas
+ 1.888.COVANCE（+1.888.268.2623） 1.609.452.4440Europe/Africa
+00.800.2682.2682 +44.1423.500888Asia/Pacific
+800.6568.3000 +65.6.5686588Global Office Locations
-
Media Relations
Request an Interview Request a Speaker亚博全站官网
设备订购投资者
Investor RelationsJob Seekers
Covance Careers
Neurology Biomarkers
当您寻求满足患有神经退行性疾病的患者的需求时，如阿尔茨海默氏症和帕金森病，有效的生物标志物战略可以帮助加速您的药物发展计划。了解如何制定有效且有效的途径，将生物标志物纳入临床试验，并主动计划商业化。
Copyright © 2020 Covance Inc. All rights reserved.
Covance is a business segment of LabCorp, a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.
Covance is a business segment of LabCorp, a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.